Pages that link to "Item:Q5714615"
From MaRDI portal
The following pages link to Determining a Maximum‐Tolerated Schedule of a Cytotoxic Agent (Q5714615):
Displayed 5 items.
- Bayesian models and decision algorithms for complex early phase clinical trials (Q903294) (← links)
- A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients (Q2861803) (← links)
- Using Joint Utilities of the Times to Response and Toxicity to Adaptively Optimize Schedule–Dose Regimes (Q2861956) (← links)
- DICE: A Bayesian model for early dose finding in phase I trials with multiple treatment courses (Q6068878) (← links)
- Bayesian dose regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics (Q6079344) (← links)